Ruffer Investment Company: Defensive strategy and positioning for volatile markets (LON:RICA) 27 January 2026
Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities 4 March 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
ISA Investing Fund Ideas, Ruffer Investment Company, Positive Returns In Any Market Cycle 6 March 2026
TESCO PLC (TSCO.L) Stock Analysis: Navigating the Grocery Giant’s 3% Dividend Yield and Growth Prospects 9 March 2026
Whitbread PLC (WTB.L) Stock Analysis: Evaluating a 15% Potential Upside Amid Mixed Ratings 9 March 2026
Weir Group PLC (WEIR.L): Investor Outlook Reveals 12.65% Potential Upside for Specialty Industrial Machinery Leader 9 March 2026
Vodafone Group PLC (VOD.L) Investor Outlook: Navigating High P/E and Dividend Commitments 9 March 2026
Ruffer Investment Company: Defensive strategy and positioning for volatile markets (LON:RICA) 27 January 2026
Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities 4 March 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
ISA Investing Fund Ideas, Ruffer Investment Company, Positive Returns In Any Market Cycle 6 March 2026
TESCO PLC (TSCO.L) Stock Analysis: Navigating the Grocery Giant’s 3% Dividend Yield and Growth Prospects 9 March 2026
Whitbread PLC (WTB.L) Stock Analysis: Evaluating a 15% Potential Upside Amid Mixed Ratings 9 March 2026
Weir Group PLC (WEIR.L): Investor Outlook Reveals 12.65% Potential Upside for Specialty Industrial Machinery Leader 9 March 2026
Vodafone Group PLC (VOD.L) Investor Outlook: Navigating High P/E and Dividend Commitments 9 March 2026
Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 151% Upside Potential in Biotech 17 February 2026
IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Exploring a 65% Upside Potential in Precision Oncology 17 February 2026
Teladoc Health, Inc. (TDOC) Stock Analysis: Unpacking a 92% Potential Upside for Investors 17 February 2026
Vera Therapeutics, Inc. (VERA) Stock Analysis: Unraveling the 78% Potential Upside in Biotechnology 17 February 2026
Adaptive Biotechnologies (ADPT) Stock Analysis: Unpacking a 30% Upside Potential in Biotechnology 17 February 2026
Kymera Therapeutics, Inc. (KYMR) Stock Analysis: 41.75% Upside Potential with Robust Analyst Ratings 17 February 2026
NewAmsterdam Pharma (NAMS) Stock Analysis: Potential 41% Upside Beckons Investors Despite Current Challenges 17 February 2026
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 225.8% Upside in the Biotech Sector 17 February 2026
Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Bold Bet with 131.99% Potential Upside 17 February 2026
Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 39.57% Upside Potential 17 February 2026
LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 28% Upside Potential 17 February 2026
DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A High-Yield Dividend Play Amidst Challenging Metrics 17 February 2026
CG Oncology, Inc. (CGON) Stock Analysis: A 55% Upside Potential in the Biotech Sector 17 February 2026
Kiniksa Pharmaceuticals Interna (KNSA) Investor Outlook: Eyeing a 21% Upside with Strong Buy Ratings 17 February 2026
Beam Therapeutics Inc. (BEAM) Stock Analysis: Unlocking a 69% Potential Upside in Genetic Medicine 17 February 2026
NovoCure Limited (NVCR) Stock Analysis: Unveiling a 129% Upside Potential in the Tumor Treating Fields Market 17 February 2026
ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Potential 41.67% Upside Amid Robust CNS Drug Portfolio 17 February 2026
Real Estate Credit Investments: Why 95% of Investors Voted to Stay In While Rivals Wind Down (Video) 5 January 2026
Real Estate Credit Investments Profiting From the Blind Spots in Property Lending (Video) 5 January 2026
NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video) 19 December 2025
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video) 17 December 2025
FTSE 100 Rises to Record on HSBC Earnings, Mining Gains Offset by Consumer Sector Weakness 25 February 2026
Ruffer Investment Company: Defensive strategy and positioning for volatile markets (LON:RICA) 27 January 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
ISA Investing Fund Ideas, Ruffer Investment Company, Positive Returns In Any Market Cycle 6 March 2026
Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities 4 March 2026
TESCO PLC (TSCO.L) Stock Analysis: Navigating the Grocery Giant’s 3% Dividend Yield and Growth Prospects 9 March 2026
Whitbread PLC (WTB.L) Stock Analysis: Evaluating a 15% Potential Upside Amid Mixed Ratings 9 March 2026
Weir Group PLC (WEIR.L): Investor Outlook Reveals 12.65% Potential Upside for Specialty Industrial Machinery Leader 9 March 2026
Vodafone Group PLC (VOD.L) Investor Outlook: Navigating High P/E and Dividend Commitments 9 March 2026
